 
 
SURVEILLANCE
 
 
 
Table
 
1
.
 
Confirmed
 
and suspected
 
cases of 
COVID
-
19
 
acute respirato
ry disease reported by provinces, regions and 
cities 
in China, 
2
6
 
February 2020
 
Province/ 
 
Region/ 
 
City
 
Population 
(10,000s)
 
Daily
 
Cumulative
 
Confirmed 
cases
 
 
Suspected 
cases
 
 
Deaths
 
Confirmed 
cases
 
Deaths
 
Hubei
 
5917
 
401
 
311
 
52
 
65187
 
2615
 
Guangdong
 
11346
 
0
 
0
 
0
 
1347
 
7
 
Henan
 
9605
 
0
 
1
 
0
 
1271
 
19
 
Zhejiang
 
5737
 
0
 
2
 
0
 
1205
 
1
 
Hunan
 
6899
 
0
 
1
 
0
 
1016
 
4
 
Anhui
 
6324
 
0
 
0
 
0
 
989
 
6
 
Jiangxi
 
4648
 
0
 
0
 
0
 
934
 
1
 
Shandong
 
10047
 
1
 
1
 
0
 
756
 
6
 
Jiangsu
 
8051
 
0
 
0
 
0
 
631
 
0
 
Chongqing
 
3102
 
0
 
9
 
0
 
576
 
6
 
Sichuan
 
8341
 
2
 
7
 
0
 
531
 
3
 
Heilongjiang
 
3773
 
0
 
0
 
0
 
480
 
12
 
Beijing
 
2154
 
0
 
21
 
0
 
400
 
4
 
Shanghai
 
2424
 
1
 
46
 
0
 
336
 
3
 
Hebei
 
7556
 
1
 
0
 
0
 
312
 
6
 
Fujian
 
3941
 
0
 
0
 
0
 
294
 
1
 
Guangxi
 
4926
 
0
 
2
 
0
 
252
 
2
 
Shaanxi
 
3864
 
0
 
0
 
0
 
245
 
1
 
Yunnan
 
4830
 
0
 
7
 
0
 
174
 
2
 
Hainan
 
934
 
0
 
6
 
0
 
168
 
5
 
Guizhou
 
3600
 
0
 
0
 
0
 
146
 
2
 
Tianjin
 
1560
 
0
 
14
 
0
 
135
 
3
 
Shanxi
 
3718
 
0
 
1
 
0
 
133
 
0
 
Liaoning
 
4359
 
0
 
6
 
0
 
121
 
1
 
Jilin
 
2704
 
0
 
2
 
0
 
93
 
1
 
Gansu
 
2637
 
0
 
0
 
0
 
91
 
2
 
Hong Kong SAR
 
745
 
4
 
0
 
0
 
85
 
2
 
Xinjiang
 
2487
 
0
 
0
 
0
 
76
 
2
 
Inner Mongolia
 
2534
 
0
 
0
 
0
 
75
 
0
 
Ningxia
 
688
 
0
 
2
 
0
 
71
 
0
 
Taipei and environs
 
2359
 
2
 
0
 
0
 
32
 
1
 
Qinghai
 
603
 
0
 
0
 
0
 
18
 
0
 
Macao SAR
 
66
 
0
 
0
 
0
 
10
 
0
 
Xizang
 
344
 
0
 
0
 
0
 
1
 
0
 
Total
 
142823
 
412
 
439
 
52
 
78191
 
2718
 
 
 
 
 
 
 
  
 
Table
 
2
. Countries, territories or areas 
outside China 
with report
ed 
laboratory
-
confirmed 
COVID
-
19
 
cases 
and 
deaths
. Data as of
 
2
6
 
February 2020
 
Country/Territory/Area
 
Confirmed
*
 
cases (new)
 
 
Likely place of exposure

 
Total cases with site of 
transmission under 
investigation (new)
 
Total 
deaths 
(new)
 
China 
(new)
 
Outside 
reporting 
country and
 
o
utside China 
(new)
 
In 
reporting 
country 
(new)
 
Western Pacific Region
 
Republic of Korea
 
1261 (284)
 
13 (0)
 
4 (0)
 
605 (0)
 
639 (284)
 
12 (2)
 
Japan
 
164 (7)
 
28 (0)
 
8 (1)
 
116 (6)
 
12 (0)
 
1 (0)
 
Singapore
 
91 (1)
 
24 (0)
 
0 (0)
 
67 (1)
 
0 (0)
 
0 (0)
 
Australia
 
23 (1)
 
12 (0)
 
8 (1)
 
3 (0)
 
0 (0)
 
0 (0)
 
Malaysia
 
22 (0)
 
18 (0)
 
2 (0)
 
2 (0)
 
0 (0)
 
0 (0)
 
Viet Nam
 
16 (0)
 
8 (0)
 
0 (0)
 
8 (0)
 
0 (0)
 
0 (0)
 
Philippines
 
3 (0)
 
3 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
1 (0)
 
Cambodia
 
1 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
South
-
East Asia Region
 
Thailand
 
40 (3)
 
23 (0)
 
0 (0)
 
7 (0)
 
10 (3)
 
0 (0)
 
India
 
3 (0)
 
3 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Nepal
 
1 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Sri Lanka
 
1 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Region of the Americas
 
United States of America
 
53 (0)
 
14 (0)
 
36 (0)
 
2 (0)
 
1 (0)
 
0 (0)
 
Canada
 
10 (0)
 
7 (0)
 
1 (0)
 
1 (0)
 
1 (0)
 
0 (0)
 
European Region
 
Italy
 
322 (93)
 
3 (0)
 
0 (0)
 
121 (0)
 
198 (93)
 
11 (5)
 
Germany
 
18 (2)
 
2 (0)
 
2 (2)
 
14 (0)
 
0 (0)
 
0 (0)
 
The United Kingdom
 
13 (0)
 
2 (0)
 
10 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
France
 
12 (0)
 
5 (0)
 
0 (0)
 
7 (0)
 
0 (0)
 
1 (0)
 
Austria
 
2 (2)
 
0 (0)
 
2 (2)
 
0 (0)
 
0 (0)
 
0 (0)
 
Croatia
 
2 (2)
 
0 (0)
 
1 (1)
 
0 (0)
 
1 (1)
 
0 (0)
 
Israel
 
2 (0)
 
0 
(0)
 
2 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Russian Federation
 
2 (0)
 
2 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Spain
 
2 (0)
 
0 (0)
 
2 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Belgium
 
1 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Finland
 
1 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Sweden
 
1 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 
(0)
 
0 (0)
 
Switzerland
 
1 (1)
 
0 (0)
 
1 (1)
 
0 (0)
 
0 (0)
 
0 (0)
 
Eastern Mediterranean Region
 
Iran (Islamic Republic of)
 
95 (34)
 
0 (0)
 
0 (0)
 
28 (0)
 
67 (34)
 
15 (3)
 
Bahrain
 
26 (18)
 
0 (0)
 
26 (18)
 
0 (0)
 
0 (0)
 
0 (0)
 
United Arab Emirates
 
13 (0)
 
6 (0)
 
2 (0)
 
5 
(0)
 
0 (0)
 
0 (0)
 
Kuwait
 
12 (4)
 
0 (0)
 
12 (4)
 
0 (0)
 
0 (0)
 
0 (0)
 
Iraq
 
5 (4)
 
0 (0)
 
5 (4)
 
0 (0)
 
0 (0)
 
0 (0)
 
Oman
 
4 (2)
 
0 (0)
 
4 (2)
 
0 (0)
 
0 (0)
 
0 (0)
 
Afghanistan
 
1 (0)
 
0 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
Egypt
 
1 (0)
 
0 (0)
 
0 (0)
 
1 (0)
 
0 (0)
 
0 (0)
 
Lebanon
 
1 (0)
 
0 
(0)
 
1 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
African Region
 
Algeria
 
1 (1)
 
0 (0)
 
1 (1)
 
0 (0)
 
0 (0)
 
0 (0)
 
 
Subtotal for all regions
 
2227 (459)
 
179 (0)
 
131 (37)
 
988 (7)
 
929 (415)
 
41 (10)
 
International conveyance

 
(Diamond Princess)
 
691 (0)
 
0 (0)
 
0 (0)
 
0 (0)
 
691 (0)
 
3 
(0)
 
Grand total
ยง
 
2918 (459)
 
179 (0)
 
131 (37)
 
988 (7)
 
929 (415)
 
44 (10)
 
*
Case classifications are
 
based on 
WHO case 
definitions
 
for 
COVID
-
19
.
 
 

Location of transmission is classified based on WHO analy
sis of available official 
data and
 
may be subject to reclassification as additional data become available.
 

Cases identified on a cruise ship currently in Japanese territorial waters.
 
ยง
217 female/294 male/2407 unknown. 22 healthcare workers (4 female/8 male/ 10 unknown). 
 
  
 
Figure 2.
 
Epidemic curve 
of 
COVID
-
19
 
cases
 
(n=
3
12)
 
identified outside of China,
 
by date of onset 
of symptoms 
and 
likely exposure location
,
 
2
6
 
February
 
2020
 
 
 
 
 
Note for figure 2: Of the 
2918
 
cases reported outside China, 
8
6
 
were detected while 
apparently 
a
symptomatic. For 
the remaining 
2832
 
cases, information on date of onset is available only for the 
3
12
 
cases presented in the 
epidemiologic curve.
 
 
 
Figure 3.
 
Ep
idemic curve of 
COVID
-
19
 
cases 
(n=
2
918
) 
identified outside of China, by date of report
 
and likely 
exposure location
, 
2
6
 
February
 
2020
 
 
 
 
 
 
 
 
  
 
 
 
PREPAREDNESS AND RESPONSE
 
 

 
To view 
all 
technical guidance documents
 
regarding 
COVID
-
19
, please go to 
this webpage
.
 

 
WHO is working 
closely 
with International Air Transport Association (
IATA) and have jointly developed a 
guidance document to provide advice to
 
ca
bin crew
 
and airport workers, based on 
country queries. The 
guidance can be found on the 
IATA webpage
. 
 

 
WHO has developed 
a protocol for the investigation of early 
cases (

First Few X (FFX) Cases and contact 
investigation protocol for 2019
-
novel coron
avirus (2019
-
nCoV) infection

)
. The protocol is designed to gain an 
early understanding of the key clinical, epidemiological and virological characteristics of the first cases of 
COVID
-
19
 
infection detected in 
any individual country, 
to inform the devel
opment and updating of public health 
guidance to manage cases and reduce potential spread and impact of infection. 
 

 
WHO
 
has
 
been
 
in
 
regular
 
and
 
direct
 
contact
 
with
 
Member
 
States
 
where
 
cases
 
have
 
been
 
reported.
 
WHO is also 
informing other countries about th
e situation and providing support as requested.
 

 
WHO has d
eveloped interim guidance for
 
laboratory diagnosis
, 
advice on the use of masks during home care and 
in health care settings in the context of the novel coronavirus (2019
-
nCoV) outbreak,
 
clinical management
,
 
infection prevention and control in health care settings,
 
home care for patients with suspected novel 
coronavirus
,
 
risk communication and community engagement
 
and 
Global Surveillance for human infection with 
novel coronavirus (2019
-
nCoV)
.
 

 
WHO has p
repared 
disease commodity package
 
that includes an essential list of biomedical equipment, 
medicines and supplies necessary to care for patients with 2019
-
nCoV.
 
 

 
WHO has p
rovided recommendations to reduce risk of 
transmission from animals to huma
ns
.
 

 
WHO has published an 
updated advice for international traffic in relation to the outbreak of the novel 
coronavirus 2019
-
nCoV
.
 

 
WHO has a
ctivat
ed
 
of R&D blueprint to accelerate diagnostics, vaccines, and therapeutics.
 

 
WHO has developed 
online courses on the following topics: 
 
A general introduction to emerging respiratory 
viruses,
 
including novel coronaviruses (available in 
French
, 
Chinese
, and 
Spanish
);  
Critical Care of Severe Acute 
Respiratory
 
Infections
; and 
Health and safety briefing for respiratory diseases 
-
 
ePROTECT
 

 
WHO is providing guidance on early investigations, which are critical to carry out early in an
 
outbreak of a new 
virus. The data collected from the protocols can be used to refine recommendations for surveillance
 
and case 
STRATEGIC OBJECTIVES
 
 

o
:
 
 

 
Limit human
-
to
-
human 
transmission including reducing secondary infections among close contacts and 
health care workers, preventing transmission amplification events, and preventing further international 
spread from China*;
 
 

 
Identify, isolate and care for patients early, includ
ing providing optimized care for infected patients;
 

 
Identify and reduce transmission from the animal source;
 

 
Address crucial unknowns regarding clinical severity, extent of transmission and infection, treatment 
options, and accelerate the development of di
agnostics, therapeutics and vaccines;
 

 
Communicate critical risk and event information to all communities and counter misinformation;
 

 
Minimize social and economic impact through multisectoral partnerships.
 
 
*
This can be achieved through a combination of pub
lic health measures, such as rapid identification, diagnosis 
and management of the cases, identification and follow up of the contacts, infection prevention and control in 
health
 
care settings, implementation of health measures for travelers, awareness
-
rai
sing in the population
 
and 
risk communication.
 
  
 
definitions, to characterize the key epidemiological transmission features of 
COVID
-
19,
 
help understand spread, 
severity, spectr
um of disease, impact on the community and to
 
inform operational models for implementation of 
countermeasures such as case isolation, contact
 
tracing and isolation.
 
Several protocols are available here: 
https://www.who.int/emergencies/diseases/novel
-
coronavirus
-
2019/technical
-
guidance/early
-
investigations
 
 

 
WHO is working with its networks of researchers and other experts to coordinate global work on surveillance, 
epidemiology, modelling, diagnostics, clin
ical care and treatment, and other ways to identify, manage the 
disease and limit onward transmission. WHO has issued interim guidance for countries, 
which are 
updated 
regularly
.
 

 
WHO is working with 
global expert networks and partnerships for laboratory, i
nfection prevention and control, 
clinical management and mathematical modelling.
 
 
RECOMMENDATIONS AND ADVICE
 
FOR THE PUBLIC
 
 
If you are not in an area where COVID
-
19 is spreading, or if you have not travelled from one of those areas or have 
not been in clo
se contact with someone who has and is feeling unwell, your chances of getting it are currently low. 

facts to help you accurately determine
 
your risks so that you can take reasonable precautions. (See 
Frequently Asked 
Questions
) Your healthcare provider, your national public health authority and your employer are all potential 
sources of accurate information on COVID
-
19 and whether it is in your area. It is important to be informed of the 
situation where you live and take approp
riate measures to protect yourself. (See  
Protection measures for 
everyone
).
 
If you are in an area where there is an outbreak of COVID
-
19 you need to take the risk of infection seriously. Follow 
the advice issued
 
by national and local health authorities. Although for most people COVID
-
19 causes only mild 
illness, it can make some people very ill. More rarely, the disease can be fatal. Older people, and those with pre
-
existing medical conditions (such as high blood
 
pressure, heart problems or diabetes) appear to be more vulnerable. 
(See 
Protection measures for persons who are in or have recently visited (past 14 days) areas where COVID
-
19 is 
spreading
).
 
 
 
